By blocking FAK kinase activity and the interaction between FAK and ASAP1, PROTAC 3 exhibits high efficacy in inhibiting invasion and metastasis of ovarian cancer cells (Huo et al., 2022). This evidence concerns the gene PTK2 and ovarian cancer.